Take part in this webinar, where will discuss the New Declaration of Helsinki and how institutions can take practical steps to institute an ethical and effective data sharing program.

Join us on Thursday, January 23 at 8am PST/11am EST/4pm GMT, for a discussion with Vivli’s CEO Rebecca Li and COO Julie Wood about the top five questions companies or non-profit foundations should ask when they are considering embarking on a data sharing program.

Register

Topics include:

• Why should we share clinical trial data?
• When should we begin a data sharing program?
• How do we start to build a data sharing program?
• How can we manage a data sharing program?
• What can a partner like Vivli do for us?

Speakers:

• Rebecca Li, CEO, Vivli
• Julie Wood, COO, Vivli

Register

This event was held at Harvard Faculty Club in Cambridge, MA, on Friday, November 15, for the 2024 Vivli Annual Meeting, co-hosted with the MRCT Center of Brigham and Women’s Hospital and Harvard. The meeting focuses on Innovations in Data Sharing and features a keynote address from Steffen Thirstrup, CMO of the EMA. He speaks on the European Health Data Space.

 

RECORDINGS SPEAKER BIOGRAPHIES

Session topics focus on the following areas:

• Keynote address: Steffen Thirstrup, EMA on European Health Data Space
• Panel discussion on European Health Data Space
• Health Information Exchanges
• Risks and Opportunities in AI and data sharing

Agenda

---

 

Keynote: Steffen Thirstrup, CMO, European Medicines Agency (EMA)

Looking to the future: The opportunities for data sharing and the European Health Data Space

RECORDING

---

Panel Discussion: The Opportunities for data sharing and the European Health Data Space (EHDS)

Following on from the keynote address, panelists discuss the potential of the EHDS.

Moderator: Rebecca Li, CEO and Co-founder, Vivli

• David Leventhal, Data Sharing & Disclosure Lead, Pfizer
• David McAllister, Professor of Clinical Epidemiology and Medical Informatics, University of Glasgow
• Steffen Thirstrup, CMO, EMA
• Aneta Tyszkiewicz, Director, Digital & Data, EFPIA

RECORDING

---

Panel Discussion: Use of Health Information Exchange (HIE) data for research: legal and ethical challenges

The panel discusses challenges related to the use of HIEs and other U.S. data sharing frameworks for research purposes, including research recruitment, retrospective studies, and more.

Moderator: Barbara Bierer, Faculty Director, MRCT and Vivli co-founder

• Jill De Graff, VP of Regulatory, b.well Connected Health
• Irene Koch, Executive Vice President and Chief Legal Officer, Hospital for Special Surgery, New York City
• David Peloquin, Partner, Ropes & Gray

RECORDING

---

Panel Discussion: Risks and Opportunities in AI and data sharing

Panelists discuss AI’s risks and opportunities for sharing and re-using data today and in the coming years.

Moderator: Ida Sim, Professor of Medicine and Computational Precision Health, University of California San Francisco; Vivli co-founder

• Karla Childers, Head, Bioethics-based Science & Technology Policy, Johson & Johnson
• Dawei Lin, Associate Director for Bioinformatics & Senior Advisor to the Director at DAIT, NIAID, NIH
• Subha Madhavan, Vice President & Head of AI/ML, Quantitative & Digital Sciences, Research and Development, Pfizer and Vivli Board member
• David Peloquin, Partner, Ropes & Gray

RECORDING

---

 

Vivli held a webinar to discuss recent developments in data privacy laws and their impact on data sharing.

This webinar was held at 5pm CEST / 11am EDT / 8am PDT on Friday, April 12th

VIEW THE RECORDING

Over the past few weeks there have been significant U.S. executive and congressional actions related to restricting transactions, data transfers, and certain types of contracts with China, other countries of concern (e.g., Russia), and individuals and businesses connected with these countries. Principally, this includes President Biden’s Executive Order (“EO”) on bulk sensitive personal data transfers and the corresponding U.S. Department of Justice Advance Notice of Proposed Rulemaking (“ANPRM”), the unanimous passage by the U.S. House of Representatives of the Protecting Americans’ Data from Foreign Adversaries Act, and the passage of the BIOSECURE Act by a critical Senate Committee.

All three of these developments, if finalized, will have important impacts on the sharing of data and biospecimens with China and certain other jurisdictions that have been labeled “countries of concern.” In this presentation, Ropes & Gray partner, David Peloquin, will walk through these different proposed regulations and legislation, focusing on the implications they each may have for research data sharing. He will also discuss the different timelines and comment periods for the EO and ANPRM, as well as the current status of each of the pending pieces of legislation.

Speaker:

• David Peloquin, Partner, Ropes & Gray

Learning objectives for this session include:

• Understanding the basics of the EO, the ANPRM, the BIOSECURE Act and the Protecting Americans’ Data from Foreign Adversaries Act
• Understanding how each of these proposed regulations or pieces of legislation may affect research data sharing with China and other countries of concern
• Understanding the potential timelines for implementation of each of these proposed regulations and pieces of legislation

VIEW THE RECORDING

Please join Vivli at the National Academy of Medicine in Washington, DC on November 16, 2023 in Washington, D.C. for a strategic meeting to collectively reflect on the seminal 2015 IOM report Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk to see how far we have come and chart a course to meet the challenges and opportunities that lie ahead.

PROCEEDINGS RECORDINGS

Session topics will focus on the following areas:

• Welcome by Victor J Dzau, NAM President
• IOM Report – 2015 Recommendations and Challenges Ahead
• The value of data sharing realized –Use Cases
• Credit and incentivizing the academic culture
• Key technologies that will influence data sharing (machine learning, AI)
• Regulations and policies to promote data sharing and re-use
• Shaping inputs and directions for the next 10 years

We look forward to welcoming researchers, data contributors, publishers, funders and other interested stakeholders to this event as we work together to set a direction for data sharing and develop an action plan for the next 10 years.

This event is free, but registration is mandatory. Please register as soon as possible, as in-person space is limited. Virtual attendees will be able to view and ask questions of presenters. For virtual attendees, participation in the breakout groups and direction setting sessions will be limited. Please email support@vivli.org with any questions.

Agenda

 

Dr. Robert Califf, FDA Commissioner, will address the meeting as the morning keynote speaker; and Dr. Monica Bertagnolli, Director of the National Institutes of Health (NIH), will join as the lunchtime keynote speaker on Thursday, November 16th. Dr. Bertagnolli’s lunchtime keynote presentation will be available to those participants attending in person.

Dr. Bertagnolli is the second woman to lead the NIH on a permanent basis. Previously, Bertagnolli served as Director of the National Cancer Institute and has served as the Richard E. Wilson Professor of Surgery in the field of surgical oncology at Harvard Medical School, a surgeon at Brigham and Women’s Hospital, and a member of the Gastrointestinal Cancer Treatment and Sarcoma Centers at Dana-Farber Cancer Institute. She has also contributed to multiple initiatives focused on transforming the data infrastructure for clinical research.

Dr. Robert M. Califf was confirmed as the 25th Commissioner of Food and Drugs in 2022. He also served in 2016 as the 22nd Commissioner, and immediately prior to that as the FDA’s Deputy Commissioner for Medical Products and Tobacco. He has spent a good portion of his career affiliated with Duke University, where he served as a professor of medicine and vice chancellor for clinical and translational research, director of the Duke Translational Medicine Institute, and was the founding director of the Duke Clinical Research Institute.

The 2015 IOM Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk Recommendations and Challenges ahead
Should we collectively set a new “north star” for the next 10 years?

Moderator: Bernard Lo, M.D., Professor of Medicine Emeritus, University of California San Francisco

• Jeffrey M. Drazen, M.D. NEJM Group Editor, The New England Journal of Medicine
• Professor Arti K. Rai, Elvin R. Latty Professor of Law, Duke Law
• Ida Sim M.D., Ph.D., Professor of Medicine and Computational Precision Health, University of California San Francisco; Vivli co-founder
• Joanne Waldstreicher, M.D., Independent Director, Becton Dickinson and Structure Therapeutics; Former Chief Medical Officer, Johnson & Johnson (retired); Faculty Affiliate, Division of Medical Ethics, New York University School of Medicine

The Value of Data Sharing Realized
This session will focus on real-life case studies that show the fruition of efforts to share data and its impact on science.

Moderator: Murray Stewart, M.D., Chief Medical Officer, Rhythm Pharmaceuticals, Inc., Vivli Board member

• Ricardo Jorge de Oliveira Ferreira, Ph.D., Auxiliary Researcher at the Nursing Research, Innovation and Development Centre of Lisbon (CIDNUR), Nursing School of Lisbon (ESEL)
• Richard Liwski, Chief Technology Officer and Director, Critical Path Institute’s Data Collaboration Center
• Rebecca Li, Ph.D., CEO and co-founder, Vivli
• Sarah Nevitt, Ph.D., Senior Research Fellow, Centre for Reviews and Dissemination, University of York
• Ronald Summers, M.D., Ph.D., Senior Investigator, Imaging Biomarkers and Computer-Aided Diagnosis Laboratory, NIH Clinical Center

 

Credit and Incentivizing the Academic Culture
With the recent policy announcements by the White House and the newly updated NIH Data Management and Sharing Policy, movements are afoot to prompt academic researchers to share. What more can be done to encourage academic researchers to share their data by leveraging incentives?

Moderator: Barbara Bierer, M.D., Faculty Director, MRCT Center, Brigham and Women’s Hospital; Professor of Medicine, Harvard Medical School; Director Regulatory Foundations, Ethics and Law, Harvard CTSA; Vivli co-founder

• Elliott Antman, M.D., Director, Harvard Postgraduate Program in Clinical/Translational Science, Professor of Medicine, Harvard Medical School
• Daniel Ernest Ford, M.D., M.P.H., Director & Professor of Medicine, Senior Associate Dean for Clinical and Translational Research, Johns Hopkins Institute for Clinical and Translational Research
• Benjamin Pierson, Deputy Director, Enterprise Data, Bill & Melinda Gates Foundation

 

Key Technologies that will Influence Data Sharing (Machine learning, AI)
What role with key technologies such as Generative AI and other key technological advances play in data sharing? What are the key motivating factors and obstacles that will need to be addressed?

Moderator: Ida Sim M.D., Ph.D., Professor of Medicine and Computational Precision Health, University of California San Francisco; Vivli co-founder

• Joshua C. Mandel, M.D., Chief Architect for Healthcare, Microsoft; Lecturer on Biomedical Informatics, Harvard Medical School
• Philip Payne, Ph.D., FACMI, FAMIA, FAIMBE, FIAHSI, Director, Institute for Informatics, Data Science and Biostatistics (I2DB); Chief Data Scientist and Associate Dean of Health Information & Data Science; Washington University School of Medicine in St. Louis
• Jane Perlmutter, M.B.A., Ph.D., President and Founder, Gemini Group Consultancy

Regulations and Policies to Promote Data Sharing and Re-Use
Given recent shifts in national policies to promote data re-use as well as efforts by publishers to promote data reuse, what more can be done by regulators, national governments, publishers and other key actors to advance data sharing and subsequent re-use?

Moderator: Michael Stebbins, Ph.D., President Science Advisors. Vivli Board Chair

• Steven Kern, Ph.D., Executive Director, Global Health Labs
• Michael Lauer, M.D., Deputy Director for Extramural Research, NIH Office of the Director
• Deven McGraw, J.D., M.P.H, LLM, Lead, Data Stewardship and Data Sharing, Invitae
• Sharon Terry, M.A., Chief Executive Officer, Genetic Alliance

PROCEEDINGS RECORDINGS

Vivli is delighted to announce the addition of two keynote speakers to the agenda for our upcoming event, “Shaping the next 10 years in Data Sharing.” Dr. Robert Califf, FDA Commissioner, will address the meeting as the morning keynote speaker; and Dr. Monica Bertagnolli, Director of the US National Cancer Institute (NCI), will join as the lunchtime keynote speaker on Thursday, November 16th.

“Dr. Bertagnolli and Dr. Califf have extensively advocated for data sharing and we eagerly anticipate their insights next month on this important topic,” said CEO Rebecca Li. “We are thrilled they will be joining us.”

Bertagnolli and Califf will join a range of distinguished presenters and participants including researchers, data contributors, publishers, patient advocates, funders, and other interested stakeholders gathering to reflect on the gains made in the past 10 years of data sharing and set new goals and plans for the future.

Dr. Bertagnolli’s lunchtime keynote presentation will be available to those participants attending in person. To be part of this conversation please make a plan to join us in Washington, DC on November 16. Registration is free, but spaces are limited!

Dr. Bertagnolli joined the National Cancer Institute as its director in 2022. Prior to that she served as the Richard E. Wilson Professor of Surgery in the field of surgical oncology at Harvard Medical School, a surgeon at Brigham and Women’s Hospital, and a member of the Gastrointestinal Cancer Treatment and Sarcoma Centers at Dana-Farber Cancer Institute. She has also contributed to multiple initiatives focused on transforming the data infrastructure for clinical research.

Dr. Robert M. Califf was confirmed as the 25th Commissioner of Food and Drugs in 2022. He also served in 2016 as the 22nd Commissioner, and immediately prior to that as the FDA’s Deputy Commissioner for Medical Products and Tobacco. He has spent a good portion of his career affiliated with Duke University, where he served as a professor of medicine and vice chancellor for clinical and translational research, director of the Duke Translational Medicine Institute, and was the founding director of the Duke Clinical Research Institute.

PROCEEDINGS RECORDINGS